Want to see HK:0157 full AI Analyst Report?
0157 Stock Chart & Stats
HK$0.49
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.49
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.07 - HK$0.63
Previous CloseN/A
Volume50.00K
Average Volume (3M)13.87K
Market Cap
HK$930.98M
Enterprise ValueHK$1.15B
Total Cash (Recent Filing)HK$112.12M
Total Debt (Recent Filing)HK$319.30M
Price to Earnings (P/E)86.8
Beta-0.02
Next Earnings
Aug 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding2,002,101,000
10 Day Avg. Volume16,600
30 Day Avg. Volume13,866
Financial Highlights & Ratios
PEG Ratio-0.84
Price to Book (P/B)2.07
Price to Sales (P/S)1.82
P/FCF Ratio-10.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ReboundThe 2025 top-line recovery indicates regained demand and restored market traction after a flat 2023–2024. A sustained higher revenue base helps absorb fixed costs, supports reinvestment in brand and channels, and creates a platform for durable margin expansion if cash conversion and cost control follow.
Balance Sheet BufferA moderate balance sheet with meaningful equity provides a buffer against shocks and gives strategic flexibility to fund operations or M&A. Despite rising leverage, the existing equity base helps preserve access to capital markets and supports a multi-month runway to execute restructuring or growth initiatives.
Integrated Omnichannel ModelVertical integration and a mix of retail and service channels are structural strengths: control over product development and manufacturing reduces supplier risk and cost leakage, while direct retail/service touchpoints deepen customer relationships and enable recurring revenue and cross-selling over the medium term.
Bears Say
Persistent Cash BurnRepeated negative operating and free cash flows point to structural working-capital stress or high reinvestment needs. Reported profits have not translated to cash, increasing reliance on external funding and raising medium-term liquidity and sustainability risks if cash conversion does not improve.
Thin, Volatile MarginsLow and historically inconsistent operating margins leave little room for cost inflation or competitive pricing pressure. Volatility with prior loss years shows profits are sensitive to revenue swings, making sustainable ROE and cash generation uncertain without structural margin improvement.
Rising LeverageMaterial debt growth over recent years reduces financial flexibility and elevates interest and refinancing exposure. For a company with weak cash generation and narrow margins, higher leverage amplifies solvency and funding risks and could constrain strategic investment or force dilutive financing if conditions worsen.
Natural Beauty Bio-Technology News
0157 FAQ
What was Natural Beauty Bio-Technology Limited’s price range in the past 12 months?
Natural Beauty Bio-Technology Limited lowest stock price was HK$0.07 and its highest was HK$0.63 in the past 12 months.
What is Natural Beauty Bio-Technology Limited’s market cap?
Natural Beauty Bio-Technology Limited’s market cap is HK$930.98M.
When is Natural Beauty Bio-Technology Limited’s upcoming earnings report date?
Natural Beauty Bio-Technology Limited’s upcoming earnings report date is Aug 05, 2026 which is in 36 days.
How were Natural Beauty Bio-Technology Limited’s earnings last quarter?
Natural Beauty Bio-Technology Limited released its earnings results on Mar 09, 2026. The company reported HK$0 earnings per share for the quarter, the consensus estimate of N/A by HK$0.
Is Natural Beauty Bio-Technology Limited overvalued?
According to Wall Street analysts Natural Beauty Bio-Technology Limited’s price is currently Overvalued.
Does Natural Beauty Bio-Technology Limited pay dividends?
Natural Beauty Bio-Technology Limited pays a Annually dividend of HK$0.024 which represents an annual dividend yield of N/A. See more information on Natural Beauty Bio-Technology Limited dividends here
What is Natural Beauty Bio-Technology Limited’s EPS estimate?
Natural Beauty Bio-Technology Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Natural Beauty Bio-Technology Limited have?
Natural Beauty Bio-Technology Limited has 2,002,101,000 shares outstanding.
What happened to Natural Beauty Bio-Technology Limited’s price movement after its last earnings report?
Natural Beauty Bio-Technology Limited reported an EPS of HK$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Natural Beauty Bio-Technology Limited?
Currently, no hedge funds are holding shares in HK:0157
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Natural Beauty Bio-Technology Limited
Natural Beauty Bio-Technology Limited operates as an investment holding company, supplying skincare products and a comprehensive range of services across the People's Republic of China, Taiwan, and other global regions. Under its "Natural Beauty" brand, the firm develops and sells a diverse array of items, including skincare, beauty, aromatherapy goods, cosmetics, health supplements, and makeup. Complementing its product line, the company delivers professional services such as skin treatments, spa and beauty therapies, medical aesthetic procedures, alongside expert consulting and training in skincare and general beauty. Its network of spas further enhances these offerings with hydrotherapy, specialized facial treatments, holistic body care, and detailed skin analysis. Furthermore, the company is involved in the wholesale distribution of its beauty and skincare merchandise. Established in 1976, Natural Beauty Bio-Technology Limited is headquartered in Wan Chai, Hong Kong.
Technical Analysis
Hengan International Group Co
―
Ming Fai International Holdings
―
Shanghai Chicmax Cosmetics Co., Ltd. Class H
―
Blue Moon Group Holdings Ltd.
―
Eternal Beauty Holdings Limited
―